Your browser doesn't support javascript.
loading
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.
Narita, Shintaro; Hatakeyama, Shingo; Takahashi, Masahiro; Sakurai, Toshihiko; Kawamura, Sadafumi; Hoshi, Senji; Ishida, Masanori; Kawaguchi, Toshiaki; Ishidoya, Shigeto; Shimoda, Jiro; Sato, Hiromi; Koizumi, Atsushi; Mitsuzuka, Koji; Tochigi, Tatsuo; Tsuchiya, Norihiko; Ohyama, Chikara; Arai, Yoichi; Nomura, Kyoko; Habuchi, Tomonori.
Afiliação
  • Narita S; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. naritashintaro@gmail.com.
  • Hatakeyama S; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan. naritashintaro@gmail.com.
  • Takahashi M; Department of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Sakurai T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Kawamura S; Department of Urology, Tohoku University School of Medicine, Sendai, Japan.
  • Hoshi S; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Ishida M; Department of Urology, Yamagata University School of Medicine, Yamagata, Japan.
  • Kawaguchi T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Ishidoya S; Department of Urology, Miyagi Cancer Center, Natori, Japan.
  • Shimoda J; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Sato H; Department of Urology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Koizumi A; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Mitsuzuka K; Department of Urology, Iwate Prefectural Isawa Hospital, Oshu, Japan.
  • Tochigi T; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Tsuchiya N; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Ohyama C; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Arai Y; Department of Urology, Sendai City Hospital, Sendai, Japan.
  • Nomura K; Michinoku Japan Urological Cancer Study Group (MJUCSG), Sendai, Japan.
  • Habuchi T; Department of Urology, Iwate Prefectural Isawa Hospital, Oshu, Japan.
Int J Clin Oncol ; 25(5): 912-920, 2020 May.
Article em En | MEDLINE | ID: mdl-31919691
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article